Bioconjugate & ADC Clinical Manufacturing

Abzena provides tailored bioconjugate & ADC clinical manufacturing services supporting scalable GMP ADC production.

Preclinical and clinical manufacturing are crucial milestones in the development of your bioconjugate or ADC product. Abzena understands the importance of reliable clinical manufacturing performance. Our services are individually tailored and designed to support your ADC clinical manufacturing requirements and bioconjugate clinical supply needs from preclinical development through commercialization.

Contact Us

Abzena’s dedicated and recently upgraded bioconjugation facility in Bristol, PA, can handle a variety of batch sizes to support preclinical and clinical manufacture of bioconjugates and antibody-drug conjugates (ADCs).

Our experienced teams are committed to ensuring your program meets its preclinical, clinical and commercial goals. We have a network of aligned manufacturing facilities supporting bioconjugate manufacturing services across the lifecycle of your molecule.

As a trusted clinical manufacturing CDMO, our manufacturing services are complemented by over 20 years of expertise in process development and optimization, as well as analytics and bioassays.

Why Choose Abzena for ADC Clinical Manufacturing?

Abzena Bristol

Abzena are focused on de-risking clinical programs. We identify risks early (design, manufacturability, toxicity) to optimize ADCs before clinical entry whilst providing advanced analytics to support regulatory confidence. Through 20+ years of experience and our deep scientific expertise in ADCs, we can offer a higher probability of clinical success and smoother IND progression.

Our key advantages:

  • Fully integrated end-to-end ADC manufacturing services and expertise
  • cGMP-compliant facilities
  • High-quality clinical through commercial support
  • Specialized bioconjugation services with 20+ years of experience
  • Quality first – to patients, regulatory authorities (FDA/EMA standards), and partners
  • Recognized as a market‑leading ADC CDMO (Frost & Sullivan Radar Report, 2026)

Ask Abzena: What is ADC Clinical Manufacturing?

Bioconjugate & ADC Commercial Manufacturing - Abzena

ADC clinical manufacturing involves the cGMP production of antibody-drug conjugates and bioconjugates for preclinical and clinical studies. A specialized ADC manufacturing CDMO supports process scale-up, analytical testing, regulatory compliance, and GMP manufacturing to ensure reliable clinical supply and product quality.

Have a question? Ask Abzena

Quality & Compliance in ADC Clinical Manufacturing

What are your drug development goals? - Abzena

Quality first – to patients, regulatory authorities, and our partners.

Abzena’s Quality organization provides safe and compliant products to your patients.

Our Quality organization has a comprehensive program of quality services to ensure compliance with regulatory requirements.

In addition to our expertise, we have the technologies and analytical capabilities to handle any of your modalities; from the simple to the most complex.

Contact Us

Our Facilities

Abzena Bristol, PA, USA Facility

Bristol, PA Facility

Our modern, recently updated bioconjugate and ADC facility located in Bristol, PA, deploys the latest in technology and processing.

Our facility in Bristol have a long history of specializing in bioconjugation, quality linker payloads, highly potent materials and complex chemistry.

Our Bristol, PA facility provides preclinical, clinical through commercial manufacturing support for bioconjugate drug programs.

Contact Us

Related Content

Commercial Manufacturing

Our integrated network of technical, quality, regulatory, and program management supports the delivery of your commercial manufacturing program. We offer reliable, predictable performance under cGMP ...

Learn More

Quality Control & Stability

Accelerating your path, we develop, execute and document phase appropriate methods necessary to produce high-quality, well-characterized material and the data to support successful BLA and ...

Learn More

Regulatory Affairs

Ensuring compliance and robust regulatory strategies, we develop tailored phase-appropriate qualification, process characterization and analytical method validation strategies.

Learn More
Integrated Cell Line Development - Abzena

Let’s move medicine forward.

The asset you’re developing right now can make a real difference for human health. Let us apply our wealth of experience to accelerate and maximize its potential.

Contact Us